Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations].

Gynecologie, obstetrique & fertilite - 1 Apr 2003

Cabaret A S, Levêque J, Dugast C, Blanchot J, Grall J Y

Abstract excerpt

Breast and ovarian cancer occur more frequently in young women with BRCA 1 &2 mutations (respective cumulative risks from 37 to 85% and 10 to 20%), and raise specific gynaecologic problems as prophylactic surgery and hormonal treatments. Two medical files from 2 sisters with BRCA 1 mutation (exon 11) are presented and the authors discuss the therapeutic options chosen. BRCA 1 & 2 tumour suppressor genes seem to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Pregnancy

Source

Identifiers

PMID: 12821070
DOI: 10.1016/s1297-9589(03)00058-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations].PMID 12821070Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

[Breast and ovarian cancer due to BRCA1&2 hereditary cancer predisposition syndrome and reproduction: literature review].Semantic proximity Read ↗

[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Semantic proximity Read ↗

[Management of gynecological tumors associated with BRCA1 and BRCA2 germline mutations. Case report and literature review].Semantic proximity Read ↗

[Identification and management of hereditary breast-ovarian cancers (2004 update)].Semantic proximity Read ↗

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].Semantic proximity Read ↗

[Recommendations for the management of women with an increased genetic risk of gynaecological cancer].Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

[Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].Semantic proximity Read ↗

Management problems. BRCA mutation, prophylactic oophorectomy and HRT.Semantic proximity Read ↗

[Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation?].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.